Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline in Severe COPD
NCT01599871Phase 3Completed
- Sponsor
- Hospital Universitari Son Espases
- Start
- Jan 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of theophylline in chronic obstructive pulmonary disease (COPD), sponsored by Hospital Universitari Son Espases. Started Jan 2011; status: completed.
02
Drugs
theophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01599871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01599871.